Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
Assisting in Toxin Removal: Glutathione binds to certain waste products, making them more water-soluble and easier for the kidneys to flush out
Among the genes evaluated, expression levels of genes were not significantly different in GHK and GHK-Cu group as compared to control
Archives of Biochemistry and Biophysics, 593 , 1223
CERTIFIED QUALITY - Vegan, kosher, gluten-free, SQF-certified U.S
Every mybest article is crafted with hours of in-depth research and interviews with experts
